-
1دورية أكاديمية
المؤلفون: Maroun Karam, Morgan Thenoz, Valérie Capraro, Jean-Philippe Robin, Christiane Pinatel, Agnès Lançon, Perrine Galia, David Sibon, Xavier Thomas, Sophie Ducastelle-Lepretre, Franck Nicolini, Mohamed El-Hamri, Youcef Chelghoun, Eric Wattel, Franck Mortreux
المصدر: Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 1, Pp 21-30 (2014)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Franck E. Nicolini, Morgan Thenoz, Youcef Chelghoun, Xavier Thomas, Sophie Ducastelle-Lepretre, Agnès Lançon, Perrine Galia, Jean-Philippe Robin, Mohamed Elhamri, Eric Wattel, Maroun Karam, Franck Mortreux, Christiane Pinatel, David Sibon, Valérie Capraro
المصدر: Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 1, Pp 21-30 (2014)
ResearcherIDمصطلحات موضوعية: Cancer Research, Chronic lymphocytic leukemia, Repressor, Biology, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Jurkat cells, lcsh:RC254-282, Chromatin, Leukemia, enzymes and coenzymes (carbohydrates), stomatognathic diseases, Transcription (biology), embryonic structures, medicine, Cancer research, Telomerase reverse transcriptase, biological phenomena, cell phenomena, and immunity, Chromatin immunoprecipitation, neoplasms
-
3
المؤلفون: Nathalie Bonnefoy-Berard, David Perol, Eric Gilson, Linda Zane, Mauricette Michallet, Eric Wattel, Claude Preudhomme, Xavier Thomas, David Sibon, Valérie Capraro, Youcef Chelghoun, Franck Mortreux, Delphine Poncet, Perrine Galia, Mohamed Elhamri
المساهمون: Laboratoire de biologie et modélisation de la cellule (LBMC UMR 5239), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École normale supérieure - Lyon (ENS Lyon)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Biostatistics, Centre Léon Bérard [Lyon], Laboratoire d'Hématologie Biologique, Centre de biologie Pathologie PM Degand, Immunité infection vaccination (I2V), Université de Lyon-Université de Lyon-IFR128-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie de Lyon (CRCL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Service d'hématologie [Hôpital Edouard Herriot - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Oncology and Biotherapies Unit, Lyon University, Service d'hématologie-oncologie adultes, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Experimental Hematology
Experimental Hematology, Elsevier, 2011, 39 (2), pp.195-202.e2. ⟨10.1016/j.exphem.2010.10.008⟩
Experimental Hematology, 2011, 39 (2), pp.195-202.e2. ⟨10.1016/j.exphem.2010.10.008⟩مصطلحات موضوعية: Cancer Research, Telomerase, Myeloid, 0302 clinical medicine, hemic and lymphatic diseases, Tumor Cells, Cultured, 0303 health sciences, MESH: Telomerase, Hematology, MESH: Gene Expression Regulation, Neoplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Telomere, Prognosis, 3. Good health, Gene Expression Regulation, Neoplastic, Leukemia, Myeloid, Acute, Leukemia, Phenotype, medicine.anatomical_structure, 030220 oncology & carcinogenesis, MESH: Survival Analysis, MESH: Leukemia, Myeloid, Acute, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, MESH: Phenotype, MESH: Prognosis, 03 medical and health sciences, Myelogenous, Telomere Homeostasis, Biomarkers, Tumor, Genetics, medicine, Humans, Telomerase reverse transcriptase, PINX1, MESH: Tumor Cells, Cultured, Molecular Biology, neoplasms, 030304 developmental biology, MESH: Precursor Cell Lymphoblastic Leukemia-Lymphoma, MESH: Humans, Cell Biology, medicine.disease, Survival Analysis, enzymes and coenzymes (carbohydrates), MESH: Tumor Markers, Biological, Cancer research, MESH: Antineoplastic Agents, MESH: Telomere